2011

/Tag:2011

Oramed Pharmaceuticals Chosen to Present at the Diabetes Technology Meeting (October 27-29, 2011; San Francisco, CA)

JERUSALEM, October 25, 2011 /PRNewswire via COMTEX/ --Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (https://www.oramed.com), a developer of oral drug delivery systems, announced today that its work entitled "Evaluation of the Safety and Efficacy of Two Oral Insulin Formulations in Healthy Volunteers" will be presented at the [...]

2018-05-30T17:04:48+00:00 Categories: Press Releases|Tags: |

Oramed Pharmaceuticals Announces Successful Phase 1 Clinical Trial Results for EnteraBio

JERUSALEM, September 27, 2011 /PRNewswire via COMTEX/ --Oramed Pharmaceuticals Inc. (OTC BB: ORMP) (https://www.oramed.com), a developer of oral delivery systems, announced that EnteraBio Ltd. recently reported successful Phase 1 clinical trial results. The Phase 1 data supports the continued development of Entera's oral osteoporosis drug. [...]

2018-05-30T17:04:48+00:00 Categories: Press Releases|Tags: |

Oramed Pharmaceuticals Chosen to Present at the 8th Annual Israel Strategic Partner and Venture Conference on September 22, 2011

JERUSALEM, September 15, 2011 /PRNewswire via COMTEX/ --Oramed Pharmaceuticals Inc. (OTC BB: ORMP.OB) (https://www.oramed.com), a developer of oral delivery systems, announced today that Ehud Arbit, M.D., the Director of R&D at Oramed, is scheduled to present at the 8th Annual Israel Strategic Partner and Venture [...]

2018-05-30T17:04:48+00:00 Categories: Press Releases|Tags: |

Oramed Pharmaceuticals to Present at The 1st Asia Pacific Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CHODy), China 2011

Oramed to Present on Friday June 3, 2011 JERUSALEM, May 18, 2011 /PRNewswire via COMTEX/ --Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (https://www.oramed.com), a developer of oral delivery systems, announced today that it was chosen to present at The 1st Asia Pacific Congress on Controversies to Consensus [...]

2018-05-30T17:04:49+00:00 Categories: Press Releases|Tags: |

Oramed Pharmaceuticals to Present at the 10th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2011

Oramed to Present on Tuesday, May 24, 2011 at 12:50 p.m. (IDT) JERUSALEM, May 11, 2011 /PRNewswire via COMTEX/ --Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (https://www.oramed.com), a developer of oral delivery systems, announced today that it was chosen to present at the 10th National Life Science [...]

2018-05-30T17:04:49+00:00 Categories: Press Releases|Tags: |

Oramed Successfully Completes Toxicity Study for ORMD-0801

JERUSALEM, March 23, 2011 /PRNewswire via COMTEX/ --Oramed Pharmaceuticals Inc. (OTC: ORMP), a developer of oral delivery systems, announced today that it has successfully completed a comprehensive toxicity study for its flagship oral insulin capsule, ORMD-0801. The study was completed under conditions prescribed by the [...]

2018-05-30T17:04:49+00:00 Categories: Press Releases|Tags: |

Oramed Pharmaceuticals Sells its Stake in Entera Bio for $1.15 Million; Buyer Also to Invest $250,000 in Oramed

JERUSALEM, February 28, 2011 /PRNewswire via COMTEX/ --Oramed Pharmaceuticals Inc. (OTCBB: ORMP), a developer of oral drug delivery systems, announced today that its subsidiary Oramed Ltd. entered into a Share Purchase Agreement with D.N.A Biomedical Solutions Ltd. (formerly Laser Detect Systems Ltd.), an Israeli company [...]

2018-05-30T17:04:50+00:00 Categories: Press Releases|Tags: |